CDH2 and melanoma: Furthermore, the combination treatment was more effective than individual agents in reducing expression of N-cadherin, vimentin and fibronectin mesenchymal marker proteins in melanoma xenografts implanted with A375 and SK-MEL-28 cells (Figure 3C and 3D).